In both trials, the most common side effect was gastrointestinal symptoms, which affected about half of the patients on either dose and about a quarter of patients on the placebo
Whether you are a good candidate for a GLP-1 (Glucagon-like peptide 1) weight-loss program depends on your health profile, medical history, lifestyle, body mass index (BMI), and other factors
However, heart disease is multifactorial
Understanding the side effect profile of each peptide helps you make informed decisions, recognize problems early, and manage issues effectively if they arise
56 The MNAM together with their oxidized compounds, 4py and 2py, are eventually eliminated in the urine